top of page
© Hairuhusiwi kukopi bila kibali cha ULYCLINIC

Mwandishi:

Mhariri:

Imeboreshwa:

ULY CLINIC

ULY CLINIC

20 Oktoba 2026, 08:12:03

Image-empty-state.png

Haematuria (blood in urine)

Assessment

  • History: duration, urinary symptoms, trauma or instrumentation, UTIs or schistosomiasis exposure, anticoagulants or herbal medicines, cancer risk (over 40 years, smoking, occupation).

  • Examination: vital signs (anaemia, shock), flank tenderness, bladder distension or masses, genitalia.

  • Tests: urinalysis and microscopy (RBC morphology), urine culture, CBC, coagulation profile; ultrasound KUB first, X-ray KUB, CT/IV urography when indicated; cystoscopy for persistent unexplained gross haematuria, especially over 40 years.

Management by cause

Cause

Management

UTI

Antibiotics by local sensitivity (e.g. nitrofurantoin, ciprofloxacin, ceftriaxone), fluids, analgesia

Schistosomiasis

Praziquantel 40 mg/kg single dose

Stones

NSAID analgesia, hydration, referral for lithotripsy or surgery if obstructed or infected

Trauma

Bed rest, analgesia, catheter if retention, surgery if severe

Suspected cancer

Urgent referral for cystoscopy and biopsy

Glomerular disease

Nephrology referral

Coagulopathy

Correct it; transfuse if severe; haematology advice

Obstruction

Relieve by catheter or surgery; monitor kidney function

  • Supportive care: hydration, monitor vital signs and Hb, transfuse only if indicated, paracetamol or NSAIDs.

  • Refer: persistent unexplained haematuria, clot retention, suspected malignancy, severe anaemia or instability.

Imeandikwa:

20 Oktoba 2026, 08:09:44

Rejea za mada hii:

  1. Ministry of Health, United Republic of Tanzania. Standard Treatment Guidelines and National Essential Medicines List for Tanzania Mainland (STG & NEMLIT). 7th ed. Dodoma: Ministry of Health; 2026. Chapter 21, Kidney and Urological Disorders: section 21.11.1 Hematuria (Tables 21.31–21.32), pp. 558–559.

bottom of page